BRIEF published on 06/17/2025 at 00:40, 5 months 18 days ago Nepra Foods Plans Non-Brokered Private Placement Private Placement Securities Investment Regulatory Approvals Nepra Foods
PRESS RELEASE published on 06/17/2025 at 00:35, 5 months 18 days ago Nepra Foods Announces Non-Brokered Private Placement Nepra Foods Inc. announces non-brokered private placement offering of up to 8,333,333 units at US$0.06 per Unit. Proceeds for general working capital. Securities not registered under 1933 Act. Visit www.neprafoods.com for more info Private Placement Securities Working Capital Non-brokered Nepra Foods Inc.
BRIEF published on 06/04/2025 at 21:35, 6 months ago Nepra Foods Clarifies Revenue Disclosure Amid Regulatory Request Regulatory Compliance Financial Disclosure Nepra Foods Profit Margins Revenue Correction
PRESS RELEASE published on 06/04/2025 at 21:30, 6 months ago Nepra Foods Inc. Issues Clarification on Revenue Disclosure Nepra Foods Inc. issues a clarification regarding financial information in response to Canadian Investment Regulatory Organization's request, highlighting corrected revenue figures and growth percentages Revenue Growth Compliance Correction Financial Clarification Nepra Foods Inc.
BRIEF published on 06/02/2025 at 22:50, 6 months 2 days ago Nepra Foods Reports Significant Revenue Growth in Q4 2025 Revenue Growth Nepra Foods Plant-based Q4 2025 Allergen-Free Foods
PRESS RELEASE published on 06/02/2025 at 22:45, 6 months 2 days ago Nepra Foods Inc. Reports Record Revenue from Major Customer and Exceptional Q4 2025 Growth Nepra Foods Inc. achieves record-breaking revenue growth in fiscal Q4 2025, showcasing success in plant-based food market expansion and partnership strength Revenue Growth Partnerships Nepra Foods Inc. Record-breaking Revenue Plant-based Food Market
BRIEF published on 04/21/2025 at 12:05, 7 months 13 days ago Nepra Foods Announces Resumption of Trading on OTCQB Investor Relations OTCQB Trading Resumption Nepra Foods Allergen-free
PRESS RELEASE published on 04/21/2025 at 12:00, 7 months 13 days ago Nepra Foods Proudly Announces Quotation On The OTCQB Nepra Foods Inc., a specialty food company, announces the resumption of trading on OTCQB. Company focuses on allergen and gluten-free food technologies OTCQB Gluten-free Nepra Foods Inc. Allergen-free Specialty Food Company
BRIEF published on 03/13/2025 at 12:05, 8 months 22 days ago Nepra Foods Seeks OTCQB Listing for Enhanced Market Visibility Market Liquidity Nepra Foods Investor Access OTCQB Upgrade Allergen-Free Ingredients
PRESS RELEASE published on 03/13/2025 at 12:00, 8 months 22 days ago Nepra Foods Applies to Upgrade to OTCQB Venture Market Nepra Foods Inc. applies to upgrade its listing to OTCQB Venture Market under symbol NPRFF to enhance transparency and investor access. Expert innovator in allergen-free foods OTCQB Venture Market Gluten-free Nepra Foods Inc. Allergen-free Investor Access
Published on 12/05/2025 at 02:35, 4 hours 36 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 11 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 6 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 11 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 11 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 40 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 20 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 45 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 56 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 11 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 26 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 27 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
